New pill targets advanced cancers in first human tests
NCT ID NCT04670679
Summary
This is an early-stage study to test the safety and find the right dose of a new oral drug called ERAS-601. It will be given to about 90 adults with advanced solid tumors that have spread, both by itself and combined with other cancer therapies. The main goals are to see how much of the drug the body can handle, how it behaves in the body, and if it shows any signs of helping to shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Comprehensive Cancer Centers of Nevada
Henderson, Nevada, 89014, United States
-
Linear Clinical Research
Perth, Western Australia, Australia
-
Mary Crowley Cancer Research
Dallas, Texas, 75251, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02215, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
-
Sarah Cannon Research Institute (Florida Cancer Specialists)
Sarasota, Florida, 34232, United States
-
Sarah Cannon Research Institute (Tennessee Oncology)
Nashville, Tennessee, 37203, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of Cincinnati
Cincinnati, Ohio, 45267, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.